PHA 📈 Premier Health of America - Overview
Exchange: V • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA74052G1063
PHA: Staffing, Nursing, Therapy, Consulting, Healthcare
Premier Health of America Inc., together with its subsidiaries, engages in the provision of staffing and outsourced service solutions for healthcare needs in Canada. It operates in two segments, Per Diem and Travel Nurse. The company provides temporary or permanent resources, including registered nurses, registered practical nurses, registered therapists, and personal support workers for public and private hospitals, medical clinics, and retirement homes. It also offers health consulting, nursing, and healthcare services in remote communities, as well as provides nursing and assistance services in remote regions; and Code Bleu, an agency to employ staff nurses. The company provides its services through PSweb, a CRM platform. It serves governments, corporations, individuals, public and private hospitals, medical clinics, and retirement homes. The company is headquartered in Blainville, Canada. Web URL: https://www.premierhealthgroup.ca
Additional Sources for PHA Stock
PHA Stock Overview
| Market Cap in USD | 5m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Facilities |
| IPO / Inception |
PHA Stock Ratings
| Growth 5y | -58.3% |
| Fundamental | -10.9% |
| Dividend | - |
| Rel. Strength Industry | -2959 |
| Analysts | - |
| Fair Price Momentum | 0.11 CAD |
| Fair Price DCF | - |
PHA Dividends
No Dividends PaidPHA Growth Ratios
| Growth Correlation 3m | -75.2% |
| Growth Correlation 12m | -90.3% |
| Growth Correlation 5y | -43.1% |
| CAGR 5y | -12.94% |
| CAGR/Mean DD 5y | -0.25 |
| Sharpe Ratio 12m | -0.38 |
| Alpha | -75.79 |
| Beta | 0.45 |
| Volatility | 145.58% |
| Current Volume | 53.5k |
| Average Volume 20d | 34.2k |
What is the price of PHA stocks?
As of December 21, 2024, the stock is trading at CAD 0.15 with a total of 53,530 shares traded.
Over the past week, the price has changed by +12.00%, over one month by +0.00%, over three months by +3.70% and over the past year by -66.67%.
As of December 21, 2024, the stock is trading at CAD 0.15 with a total of 53,530 shares traded.
Over the past week, the price has changed by +12.00%, over one month by +0.00%, over three months by +3.70% and over the past year by -66.67%.
Is Premier Health of America a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Premier Health of America is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -10.86 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PHA as of December 2024 is 0.11. This means that PHA is currently overvalued and has a potential downside of -26.67%.
Neither. Based on ValueRay Fundamental Analyses, Premier Health of America is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -10.86 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PHA as of December 2024 is 0.11. This means that PHA is currently overvalued and has a potential downside of -26.67%.
Is PHA a buy, sell or hold?
Premier Health of America has no consensus analysts rating.
Premier Health of America has no consensus analysts rating.
What are the forecast for PHA stock price target?
According to ValueRays Forecast Model, PHA Premier Health of America will be worth about 0.1 in December 2025. The stock is currently trading at 0.15. This means that the stock has a potential downside of -13.33%.
According to ValueRays Forecast Model, PHA Premier Health of America will be worth about 0.1 in December 2025. The stock is currently trading at 0.15. This means that the stock has a potential downside of -13.33%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 0.5 | 233.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.1 | -13.3% |